Free Trial

Achieve Life Sciences (ACHV) Competitors

Achieve Life Sciences logo
$2.20 -0.06 (-2.65%)
Closing price 07/3/2025 03:53 PM Eastern
Extended Trading
$2.15 -0.05 (-2.05%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ACHV vs. XOMA, VNDA, VSTM, CDXS, SGMO, AGEN, IRWD, DOMH, FBIO, and CRIS

Should you be buying Achieve Life Sciences stock or one of its competitors? The main competitors of Achieve Life Sciences include XOMA Royalty (XOMA), Vanda Pharmaceuticals (VNDA), Verastem (VSTM), Codexis (CDXS), Sangamo Therapeutics (SGMO), Agenus (AGEN), Ironwood Pharmaceuticals (IRWD), Dominari (DOMH), Fortress Biotech (FBIO), and Curis (CRIS). These companies are all part of the "biotechnology" industry.

Achieve Life Sciences vs. Its Competitors

XOMA Royalty (NASDAQ:XOMA) and Achieve Life Sciences (NASDAQ:ACHV) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

XOMA Royalty has higher revenue and earnings than Achieve Life Sciences. XOMA Royalty is trading at a lower price-to-earnings ratio than Achieve Life Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
XOMA Royalty$28.49M11.11-$13.82M-$1.15-22.99
Achieve Life SciencesN/AN/A-$39.83M-$1.34-1.64

Achieve Life Sciences has a net margin of 0.00% compared to XOMA Royalty's net margin of -13.04%. XOMA Royalty's return on equity of -12.43% beat Achieve Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
XOMA Royalty-13.04% -12.43% -4.85%
Achieve Life Sciences N/A -176.11%-103.32%

XOMA Royalty has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Comparatively, Achieve Life Sciences has a beta of 1.51, suggesting that its share price is 51% more volatile than the S&P 500.

XOMA Royalty currently has a consensus price target of $69.50, suggesting a potential upside of 162.92%. Achieve Life Sciences has a consensus price target of $14.33, suggesting a potential upside of 551.52%. Given Achieve Life Sciences' stronger consensus rating and higher probable upside, analysts plainly believe Achieve Life Sciences is more favorable than XOMA Royalty.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
XOMA Royalty
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Achieve Life Sciences
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
2 Strong Buy rating(s)
3.50

In the previous week, Achieve Life Sciences had 1 more articles in the media than XOMA Royalty. MarketBeat recorded 3 mentions for Achieve Life Sciences and 2 mentions for XOMA Royalty. XOMA Royalty's average media sentiment score of 0.23 beat Achieve Life Sciences' score of 0.11 indicating that XOMA Royalty is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
XOMA Royalty
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Achieve Life Sciences
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

95.9% of XOMA Royalty shares are held by institutional investors. Comparatively, 33.5% of Achieve Life Sciences shares are held by institutional investors. 9.1% of XOMA Royalty shares are held by insiders. Comparatively, 3.0% of Achieve Life Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

XOMA Royalty beats Achieve Life Sciences on 8 of the 15 factors compared between the two stocks.

Get Achieve Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACHV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACHV vs. The Competition

MetricAchieve Life SciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$75.61M$2.43B$5.55B$9.04B
Dividend YieldN/A1.67%5.22%4.00%
P/E Ratio-1.649.2227.6420.24
Price / SalesN/A683.41417.15117.30
Price / CashN/A158.5936.8958.10
Price / Book3.614.588.035.67
Net Income-$39.83M$31.34M$3.18B$249.21M
7 Day Performance-1.35%3.25%2.93%3.28%
1 Month Performance-42.56%3.46%1.72%3.95%
1 Year Performance-51.54%0.77%34.39%20.98%

Achieve Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACHV
Achieve Life Sciences
1.4632 of 5 stars
$2.20
-2.7%
$14.33
+551.5%
-51.5%$75.61MN/A-1.6420Gap Up
High Trading Volume
XOMA
XOMA Royalty
4.321 of 5 stars
$25.20
-8.3%
$69.50
+175.8%
+3.1%$301.64M$28.49M-21.9110Gap Up
High Trading Volume
VNDA
Vanda Pharmaceuticals
4.4052 of 5 stars
$4.72
-1.3%
$16.50
+249.6%
-4.7%$278.15M$198.77M-6.29290
VSTM
Verastem
2.6337 of 5 stars
$4.15
flat
$13.38
+222.3%
+73.7%$228.04M$10K-1.3050
CDXS
Codexis
2.9442 of 5 stars
$2.44
+2.1%
$11.00
+350.8%
-7.1%$202.15M$59.35M-2.46250
SGMO
Sangamo Therapeutics
2.7169 of 5 stars
$0.54
+0.1%
$4.50
+731.3%
+66.2%$126.22M$57.80M-1.39480
AGEN
Agenus
4.2726 of 5 stars
$4.57
-4.0%
$14.00
+206.3%
-60.8%$125.31M$103.46M-0.53440
IRWD
Ironwood Pharmaceuticals
4.5823 of 5 stars
$0.72
-1.9%
$4.78
+566.9%
-88.6%$116.06M$317.68M-3.59220
DOMH
Dominari
0.3548 of 5 stars
$5.44
-2.0%
N/A+180.3%$79.64M$18.15M-1.214Positive News
FBIO
Fortress Biotech
2.1457 of 5 stars
$1.86
+2.2%
$21.00
+1,029.0%
+6.1%$55M$57.67M-0.83170Gap Up
CRIS
Curis
2.8801 of 5 stars
$2.32
+6.9%
$17.00
+632.8%
-71.2%$24.27M$10.91M-0.3760News Coverage
High Trading Volume

Related Companies and Tools


This page (NASDAQ:ACHV) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners